Induced Sputum: A Valuable Tool for Assessing Cellular and Microbiological Characteristics in Cystic Fibrosis Expectorating Teenagers
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | M. Guedes, D. Frankel, S. A. Baron, J. Berbis, N. Stremler‐Le Bel, M. Baravalle‐Einaudi, P. Roll, E. Kaspi, J. C. Dubus |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
par: Cindy L. Williams, et autres
Publié: (2025)
par: Cindy L. Williams, et autres
Publié: (2025)
Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use
par: Khizra Farhan Ahmad, et autres
Publié: (2026)
par: Khizra Farhan Ahmad, et autres
Publié: (2026)
Initial Antibiotic Selection Based on Microbiologic History in Pediatric Cystic Fibrosis‐Related Pulmonary Exacerbations
par: Jillian Grapsy, et autres
Publié: (2025)
par: Jillian Grapsy, et autres
Publié: (2025)
Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study
par: Prawin Kumar, et autres
Publié: (2025)
par: Prawin Kumar, et autres
Publié: (2025)
Preliminary Psychometric Characteristics of the Cystic Fibrosis Coping Self‐Efficacy (CF‐CSE) Scale
par: Deborah Friedman, et autres
Publié: (2025)
par: Deborah Friedman, et autres
Publié: (2025)
Roadmap to Global Cystic Fibrosis Care
par: Samya Z. Nasr, et autres
Publié: (2025)
par: Samya Z. Nasr, et autres
Publié: (2025)
Adherence to Anti‐Staphylococcal Prophylaxis in the First Two Years of Life and Microbiological Outcomes in the First Six Years of Life in Children With Cystic Fibrosis
par: Maryanne Holmes, et autres
Publié: (2025)
par: Maryanne Holmes, et autres
Publié: (2025)
Interrater Reliability of a Modified Bronchoscopy Scoring Tool in Children With Cystic Fibrosis
par: Alexandra Bosetti, et autres
Publié: (2025)
par: Alexandra Bosetti, et autres
Publié: (2025)
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
par: Leslie Huang, et autres
Publié: (2025)
par: Leslie Huang, et autres
Publié: (2025)
Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10‐Year Observational Follow‐Up Study in France
par: Erika Guyot, et autres
Publié: (2025)
par: Erika Guyot, et autres
Publié: (2025)
Exploration of MyVoice: CF as a Reproductive Health Decision Support Tool for Adolescent Females With Cystic Fibrosis
par: Maya L. Albanowski, et autres
Publié: (2025)
par: Maya L. Albanowski, et autres
Publié: (2025)
Pathophysiology of Cystic Fibrosis Liver Disease
par: Vania L. Kasper, et autres
Publié: (2024)
par: Vania L. Kasper, et autres
Publié: (2024)
Cystic Fibrosis Year in Review 2024
par: Adrienne P. Savant
Publié: (2025)
par: Adrienne P. Savant
Publié: (2025)
Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
par: Rebecca Gallardo, et autres
Publié: (2026)
par: Rebecca Gallardo, et autres
Publié: (2026)
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
par: Emma M. Tillman, et autres
Publié: (2025)
par: Emma M. Tillman, et autres
Publié: (2025)
Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
par: Suzanne Kroes, et autres
Publié: (2026)
par: Suzanne Kroes, et autres
Publié: (2026)
E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
par: Maryam Sahibqran, et autres
Publié: (2024)
par: Maryam Sahibqran, et autres
Publié: (2024)
Expanding Cystic Fibrosis Registries to the Rest of the World
par: Lutz Naehrlich
Publié: (2026)
par: Lutz Naehrlich
Publié: (2026)
Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
par: Brittany A. Wright, et autres
Publié: (2025)
par: Brittany A. Wright, et autres
Publié: (2025)
The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
par: Rebecca J. Vitale, et autres
Publié: (2026)
par: Rebecca J. Vitale, et autres
Publié: (2026)
Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy
par: Julianna Bailey, et autres
Publié: (2026)
par: Julianna Bailey, et autres
Publié: (2026)
Anxiety in the Pediatric Cystic Fibrosis Population: Evaluation of a Younger Cohort
par: Jemilla Strode Smith, et autres
Publié: (2025)
par: Jemilla Strode Smith, et autres
Publié: (2025)
The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis
par: Aqeem Azam, et autres
Publié: (2025)
par: Aqeem Azam, et autres
Publié: (2025)
Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis
par: Rebecca S. Pettit, et autres
Publié: (2024)
par: Rebecca S. Pettit, et autres
Publié: (2024)
Disparities in Access to Cystic Fibrosis Therapy Across Countries
par: Bulent Karadag
Publié: (2026)
par: Bulent Karadag
Publié: (2026)
“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
par: Tuğba Şişmanlar Eyüboğlu, et autres
Publié: (2026)
par: Tuğba Şişmanlar Eyüboğlu, et autres
Publié: (2026)
Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis
par: Hillary S. Hayden, et autres
Publié: (2025)
par: Hillary S. Hayden, et autres
Publié: (2025)
Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
par: Jeremy P. Tervo, et autres
Publié: (2025)
par: Jeremy P. Tervo, et autres
Publié: (2025)
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
par: Gabriela R. Oates, et autres
Publié: (2025)
par: Gabriela R. Oates, et autres
Publié: (2025)
Genetic Variants and Clinical Characteristics in the Diagnosis of Children Aged Under 18 Years With Cystic Fibrosis in a Brazilian State
par: Luana da Silva Baptista Arpini, et autres
Publié: (2025)
par: Luana da Silva Baptista Arpini, et autres
Publié: (2025)
Molecular Methods to Detect and Quantify Fungal Communities in Cystic Fibrosis Airway Specimens
par: Matthew K. Fought, et autres
Publié: (2026)
par: Matthew K. Fought, et autres
Publié: (2026)
Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real‐Life Study
par: A. M. Zwitserloot, et autres
Publié: (2025)
par: A. M. Zwitserloot, et autres
Publié: (2025)
Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
par: Chelsea Flora, et autres
Publié: (2026)
par: Chelsea Flora, et autres
Publié: (2026)
Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
par: Laurie P. Murray, et autres
Publié: (2025)
par: Laurie P. Murray, et autres
Publié: (2025)
Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
par: Sean Coyne, et autres
Publié: (2024)
par: Sean Coyne, et autres
Publié: (2024)
Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
par: Elizabeth Clarke, et autres
Publié: (2024)
par: Elizabeth Clarke, et autres
Publié: (2024)
Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis
par: Lauren N. Kormelink, et autres
Publié: (2024)
par: Lauren N. Kormelink, et autres
Publié: (2024)
Pica‐Induced Airway Obstruction in Paediatric Cystic Fibrosis: An Unexpected Culprit
par: Anna Šmejkalová, et autres
Publié: (2025)
par: Anna Šmejkalová, et autres
Publié: (2025)
A Dose of Hope: Successful Tobramycin Desensitization in Pediatric Cystic Fibrosis
par: Isabel G. Wedig, et autres
Publié: (2025)
par: Isabel G. Wedig, et autres
Publié: (2025)
Knowledge, Attitudes, and Behaviors of Cystic Fibrosis Patients on Reproductive Health in Turkiye
par: Hande Yuce Ozdemir, et autres
Publié: (2025)
par: Hande Yuce Ozdemir, et autres
Publié: (2025)
Documents similaires
-
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
par: Cindy L. Williams, et autres
Publié: (2025) -
Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use
par: Khizra Farhan Ahmad, et autres
Publié: (2026) -
Initial Antibiotic Selection Based on Microbiologic History in Pediatric Cystic Fibrosis‐Related Pulmonary Exacerbations
par: Jillian Grapsy, et autres
Publié: (2025) -
Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study
par: Prawin Kumar, et autres
Publié: (2025) -
Preliminary Psychometric Characteristics of the Cystic Fibrosis Coping Self‐Efficacy (CF‐CSE) Scale
par: Deborah Friedman, et autres
Publié: (2025)